您当前的位置：
首页 >
文章列表页 >
Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1α/VEGF/TGF-β1 Pathway
更新时间：2024-03-14

    • Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1α/VEGF/TGF-β1 Pathway

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 8, Pages: 57-65(2024)

    • DOI：10.13422/j.cnki.syfjx.20232140    

      CLC： R2-0;R33;R289;R575

    • Received：18 September 2023，

      Published Online：21 December 2023，

      Published：20 April 2024

    移动端阅览

  • XING Anli,ZHAO Kunpeng,ZHANG Qiuju,et al.Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1α/VEGF/TGF-β1 Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(08):57-65. DOI： 10.13422/j.cnki.syfjx.20232140.

  •  
  •  

0

Views

35

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effect of Artesunate on Experimental Choroidal Neovascularization and Expression of HIF-1α and VEGF
Role of VEGF Signaling Pathway in Pathological Mechanism of Colorectal Cancer and Traditional Chinese Medicine Intervention： A Review
Mechanism and Combination Therapy of Berberine in Treatment of Nonalcoholic Fatty liver Disease：A Review
Clinical Efficacy of Gandou Fumu Granules in Intervention of Liver Fibrosis in WD Patients with Phlegm and Blood Stasis Syndrome and Effect on Cuproptosis-related Indicators

Related Author

XING Anli
ZHAO Kunpeng
ZHANG Qiuju
LI Jiena
CHEN Shiyu
GUO Jiaqi
ZHANG Ming
Jia-xian LI

Related Institution

Clinical College， Gansu University of Chinese Medicine
Eye Hospital， China Academy of Chinese Medical Sciences
Xiyuan Hospital， China Academy of Chinese Medical Sciences
Peking University Third Hospital
Beijing University of Chinese Medicine
0